Marine Drugs

Aims & Scope

Marine Drugs (ISSN 1660-3397) publishes peer-reviewed research papers, short notes, and reviews reporting on the discovery, development, exploitation, and production of biologically and therapeutically active compounds from marine habitats.

Our aim is to encourage scientists to publish their research in as much detail as possible; therefore, there is no restriction on the length of the manuscript.

Subject areas include: -Identification of bioactive compounds from marine microorganisms, invertebrates, fishes, and plants (e.g. algae, seagrasses, mangroves)- Pharmacological characterization of marine compounds or their derivatives- Marine natural products with activity against human, animal and plant diseases- Marine natural products with insecticidal or herbicidal activities- Synthesis, mutasynthesis and medicinal chemistry of marine natural products- Marine proteomics, glycomics, and lipidomics related to drug discovery or bioactivity- Marine drug development, including pharmaceutical formulation and clinical trials- Marine chemical ecology research inspiring marine drug discovery- Innovative sampling and isolation techniques targeting bioactive marine natural products- Marine biotechnology and molecular biology studies related to drug discovery or production- Structural and biological characterization of marine toxins- Biomaterials of marine origin- Marine-derived ingredients for cosmeceuticals, nutraceuticals, marine-derived functional foods and nutritional supplements

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Pharmacology, Toxicology and Pharmaceutics, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,900.00 CHF. Learn more.

Explore journals without APCs for alternative publishing options.